Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Icad Inc (ICAD)

Icad Inc (ICAD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 120,387
  • Shares Outstanding, K 19,262
  • Annual Sales, $ 25,620 K
  • Annual Income, $ -9,020 K
  • 60-Month Beta 1.18
  • Price/Sales 4.70
  • Price/Cash Flow N/A
  • Price/Book 11.05

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.99 +5.51%
on 08/07/19
7.45 -15.17%
on 08/01/19
-0.57 (-8.27%)
since 07/16/19
3-Month
5.37 +17.69%
on 05/17/19
7.45 -15.17%
on 08/01/19
+0.56 (+9.72%)
since 05/16/19
52-Week
2.42 +160.62%
on 11/09/18
7.45 -15.17%
on 08/01/19
+3.38 (+114.97%)
since 08/16/18

Most Recent Stories

More News
iCAD Reports Second Quarter 2019 Financial Results

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported financial results for the three and six months ended June 30, 2019....

ICAD : 6.32 (+1.12%)
iCAD to Report Second Quarter 2019 Financial Results on Thursday, August 1

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter...

ICAD : 6.32 (+1.12%)
iCAD's ProFound AI(TM) for 2D Mammography Receives CE Mark Approval

Deep-learning, artificial intelligence technology assists radiologists in detecting breast cancer

ICAD : 6.32 (+1.12%)
SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence

SimonMed Imaging, one of the largest outpatient medical imaging providers and largest physician radiology practices in the United States, announced today their implementation of the first FDA-cleared AI...

ICAD : 6.32 (+1.12%)
iCAD, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 7, 2019 / iCAD, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 8:30 AM Eastern Time.

ICAD : 6.32 (+1.12%)
iCAD Appoints R. Scott Areglado as Chief Financial Officer

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today appointed R. Scott Areglado as Chief Financial Officer. Mr. Areglado has...

ICAD : 6.32 (+1.12%)
iCAD to Report First Quarter 2019 Financial Results on Tuesday, May 7

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended...

ICAD : 6.32 (+1.12%)
iCAD Wins Three-System Public Bid with Leading Cancer Organization in Spain, Expanding European Access to Innovative Cancer Treatments with the Xoft System

Two additional Spanish centers announce adoption of the Xoft System, totaling seven installations across four major regions in Spain

ICAD : 6.32 (+1.12%)
iCAD to Highlight ProFound AI(TM) Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will present its latest artificial intelligence software...

ICAD : 6.32 (+1.12%)
iCAD Appoints Stacey Stevens as President

Appointment establishes executive infrastructure to enhance strategic and operational momentum and capitalize on significant growth opportunities

ICAD : 6.32 (+1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade ICAD with:

Business Summary

Icad, Inc. designs, engineers, develops and manufactures digital image scanners, densitometers, film digitizers and related software for applications in the graphic arts, medical imaging and life sciences markets. The Company sells its products throughout the world throughvarious distributors, resellers,...

See More

Key Turning Points

2nd Resistance Point 6.51
1st Resistance Point 6.42
Last Price 6.32
1st Support Level 6.19
2nd Support Level 6.05

See More

52-Week High 7.45
Last Price 6.32
Fibonacci 61.8% 5.53
Fibonacci 50% 4.94
Fibonacci 38.2% 4.34
52-Week Low 2.42

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar